Class 2 Device Recall Activa PC, Activa RC, Activa SC

• Date Initiated by Firm: February 27, 2014
• Date Posted: April 29, 2014
• Recall Status: Terminated on November 07, 2014
• Recall Number: Z-1525-2014
• Recall Event ID: 66841
• PMA Number: P960009S052
• Product Classification: Stimulator, electrical, implanted, for parkinsonian tremor - Product Code MHY
• Product: Medtronic Activa RC (37612), Activa PC (37601), Activa SC (37602), Activa SC (37603), Activa PC+S (37604), Multi-program Rechargeable Neurostimulator for Deep Brain Stimulation for movement disorders.
• Code Information: The first released affected product was released to the market in April, 2005.
• Recalling Firm/ Manufacturer: Medtronic Neuromodulation; 7000 Central Ave NE; Minneapolis MN 55432-3568
• For Additional Information Contact: Technical Services ; 800-707-0933
• Manufacturer Reason for Recall: Medtronic neurostimulators (used with pain and deep brain stimulation therapy) have a cycling feature that, when enabled, allows stimulation output to be toggled on and off based on the programmed settings. The use of this feature is determined by the physician and set using the clinician programmer. Current labeling indicates the use of cycling improves device longevity and recharge interval
• FDA Determined Cause: Labeling False and Misleading
• Action: Medtronic sent a Medical Device Correction letter dated February 2014 to all affected consignees. The letter identified the product, the problem, and the action to be taken by the consignee. Consignees were instructed to do the following: If you have patients with cycling enabled or wish to use cycling, use the updated calculations and graphs available online at professional.medtronic.com/cycling to assess the impact of cycling on device longevity. Medtronic will update the product labeling in the second half of 2014. " Remind your patients to continue to check their battery status. Instructions on how to check battery status can be found in the patient programmer or recharger system manual. " Pain Stimulation Trialing Only: The cycling feature should not be enabled on the External Neurostimulator (ENS) when estimating device longevity because the resulting longevity estimate for non-rechargeable devices may not provide accurate information. Consignees were also instructed to acknowledge receipt of the notice by completing the attached reply form and returning it to Medtronic using the contact details on the reply form. For questions consignees can contact Medtronic Neuromodulation Technical services at 1-800-707-0933 weekdays 7am - 6pm CST. For questions regarding this recall call 800-707-0933.
• Quantity in Commerce: 170,286 US, 73,921 OUS for all devices
• Distribution: Nationwide Distribution - all states including DC and Puerto Rico.
• Total Product Life Cycle: TPLC Device Report

¹ A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
² Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
³ For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.

• PMA Database: PMAs with Product Code = MHY